THINK Surgical Receives FDA 510(k) Clearance for Zimmer Biomet Persona Knee on TMINI® Miniature Robotic System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

FREMONT, Calif., Sept. 5, 2024 /PRNewswire/ — THINK Surgical, Inc., an innovator in the field of orthopedic surgical robots, today announced that its TMINI® Miniature Robotic System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with the Persona® The Personalized Knee System® from Zimmer Biomet.

The availability of the Persona Knee System on an exclusive version of the TMINI System is a major milestone for THINK Surgical. THINK Surgical is the only company offering a robotic system providing both an implant exclusive option with the Persona Knee System and an open implant platform for use with implants from multiple other manufacturers for total knee arthroplasty.

This go-to-market strategy supports two distinct customer segments, one which prefers an open platform where the customer can choose from a range of implants on the robot and another which prefers an exclusive platform with the market leading Persona Knee System.

“TMINI addresses surgeon demand for ergonomic, wireless, handheld robotic systems and we believe this will accelerate adoption of robotics in knee procedures, particularly in the out-patient setting.” said THINK Surgical CEO, Stuart Simpson.

About THINK Surgical, Inc. 

THINK Surgical, Inc., is a privately held U.S.-based technology innovator that develops and markets orthopedic robots. THINK Surgical robots are open platforms providing support for implant brands from multiple manufacturers, enabling the choice of implant to be driven by the surgeon. 

THINK Surgical actively collaborates with healthcare professionals around the globe to refine our orthopedic products, improving the lives of those suffering from advanced joint disease with precise, accurate, and intelligent technology.  

Please refer to the instructions for use for the TMINI Miniature Robotic System for a complete list of indications, contraindications, warnings, and precautions. For additional product information, please visit www.thinksurgical.com

THINK Surgical, TMINI and TMINI Pro are trademarks of THINK Surgical, Inc. 

Media Contact: 

THINK Surgical Inc.
Nick Margree
nmargree@thinksurgical.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/think-surgical-receives-fda-510k-clearance-for-zimmer-biomet-persona-knee-on-tmini-miniature-robotic-system-302239196.html

SOURCE THINK Surgical, Inc.

Staff

Recent Posts

Serotonin Centers Announces Landmark Southeast Florida Area Development

Leading National Anti-Aging Med Spa Franchise Signs Multi-Unit Agreement for 18 New Locations in the…

2 hours ago

General Oncology to Participate in Three Upcoming Conferences

BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated…

2 hours ago

Capricor Therapeutics Appoints Michael Binks, M.D. as Chief Medical Officer

— Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025,…

2 hours ago

AVITA Medical’s Acute Wound Care Showcase 2025 Streams Live Today

See how innovation is transforming patient outcomes through real-world clinical insights and patient storiesVALENCIA, Calif., May…

2 hours ago

Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market

BEIJING, May 13, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI),…

2 hours ago